Procedure May Restore Stevens-Johnson Affected Eyes
Researchers show how COMET procedure can restore ocular surface anatomy and revive visual performance.
All articles by Dermatology Advisor Contributing Writer
FDG-PET Superior to CT for Predicting Melanoma Relapse After Immunotherapy
The long-term outcome of patients with melanoma may be predicted by FDG-PET imaging and also influence treatment duration.
PET, CT Scans for the Staging of Malignant Melanoma
Findings suggest that PET/CT imaging should be included in the malignant melanoma treatment algorithm starting with T2 patients.
Immunotherapy Is a Viable Treatment Strategy for Advanced MCC and CSCC
The frequent and durable responses to PD-1/PD-L1–blocking antibodies confirm the importance of immune mechanisms in nonmelanoma skin cancer pathogenesis.
Video-Based Assessment May Improve Dermatology Resident Surgical Skills
The applicability of video-based assessment in providing dermatology residents with feedback on surgical technical skills and unsafe surgical practices is assessed.
Ixekizumab Superior to Secukinumab in Providing More Quality-Adjusted Life-Years in Psoriatic Arthritis
Researchers conducted cost-effectiveness analyses to compare ixekizumab and secukinumab in psoriatic arthritis and moderate to severe plaque psoriasis.
Ustekinumab, Secukinumab, and Ixekizumab Comparable for Plaque Psoriasis
Ustekinumab, secukinumab, and ixekizumab were compared for clinical effectiveness and associated adverse events in the treatment of plaque psoriasis.
Visual Functions in Psoriatic Arthritis Sine-Psoriasis May Be Linked to Systemic Inflammation
Researchers analyzed dry eye and subclinical retinal abnormalities in a cohort of patients with psoriatic arthritis sine-psoriasis.
Bidirectional Association of Alopecia Areata and Depression Found in Siblings
Shared familial mechanisms may underlie alopecia areata and major depressive disorder, and suggest a bidirectional association.
Model-Based Analysis Estimations of COVID-19 Severity
Estimates of the severity of coronavirus disease 2019 (COVID-19) using model-based analysis showed a mean time from symptom onset to death of roughly 18 days.
-
Loading...
-
Loading...
Next post in Practice Management
